Modified protocol for improvement of differentiation potential of menstrual blood-derived stem cells into adipogenic lineage

Cell Proliferation

Volumn 47, Issue 6, 2014, Pages 615-623

  Khanmohammadi, M ^a   Khanjani, S ^a   Edalatkhah, H ^a   Zarnani, A H ^a,b   Heidari Vala, H ^a   Soleimani, M ^c   Alimoghaddam, K ^d   Kazemnejad, S ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THY 1 ANTIGEN; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPOGENESIS; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL VACUOLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEPR GENE; LPL GENE; MENSTRUAL BLOOD DERIVED STEM CELL; NORMAL HUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; UPREGULATION; BONE MARROW CELL; CYTOLOGY; DRUG EFFECTS; GENETICS; MENSTRUATION; METABOLISM; YOUNG ADULT;

ADIPOGENESIS; ADULT; BONE MARROW CELLS; CELL LINEAGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEIN LIPASE; MENSTRUATION; OCTAMER TRANSCRIPTION FACTOR-3; PPAR GAMMA; RECEPTORS, LEPTIN; RNA, MESSENGER; STEM CELLS; YOUNG ADULT;

EID: 84911983390     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12133     Document Type: Article

References (33)

1. Langstein HN, Robb GL (1999) Reconstructive approaches in soft tissue sarcoma. Semin. Surg. Oncol. 17, 52-65.
2. Klein AW, Elson ML (2000) The history of substances for soft tissue augmentation. Dermatol. Surg. 26, 1096-1105.
3. Gomillion CT, Burg KJ (2006) Stem cells and adipose tissue engineering. Biomaterials 27, 6052-6063.
4. Leeper NJ, Hunter AL, Cooke JP (2010) Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem. Circulation 122, 517-526.
5. Henningson CT Jr, Stanislaus MA, Gewirtz AM (2003) Embryonic and adult stem cell therapy. J. Allergy Clin. Immunol. 111, S745-S753.
6. Zheng YH, Xiong W, Su K, Kuang SJ, Zhang ZG (2013) Multilineage differentiation of human bone marrow mesenchymal stem cells in vitro and in vivo. Exp. Ther. Med. 5, 1576-1580.
7. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L (2004) Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340, 141-150.
8. Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J et al. (2007) Endometrial regenerative cells: a novel stem cell population. J. Transl. Med. 5, 57-66.
9. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG (2008) Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant. 17, 303-311.
10. Khanjani S, Khanmohammadi M, Zarnani AH, Talebi S, Edalatkhah H, Eghtesad S et al. (2013) Efficient generation of functional hepatocyte-like cells from menstrual blood derived stem cells. J. Tissue Eng. Regen. Med. 2013 Mar 18. doi: 10.1002/term.1715. Epub ahead of print.
11. Taylor HS (2004) Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292, 81-85.
12. Khanmohammadi M, Khanjani S, Bakhtyari MS, Zarnani AH, Edalatkhah H, Akhondi MM et al. (2012) Proliferation and chondrogenic differentiation potential of menstrual blood and bone marrow-derived stem cells in two dimensional culture. Int. J. Hematol. 95, 484-493.
13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
14. Gargett CE, Masuda H (2010) Adult stem cells in the endometrium. Mol. Hum. Reprod. 16, 818-834.
15. Sousa BR, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FM, Lacerda SM et al. (2014) Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A 85, 43-77.
16. Darzi S, Zarnani AH, Jeddi-Tehrani M, Entezami K, Mirzadegan E, Akhondi MM et al. (2012) Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate. Tissue Eng. Part A 18, 1720-1728.
17. Kazemnejad S, Akhondi MA, Soleimani M, Zarnani AM, Khanmohammadi M, Darzi S et al. (2012) Characterization and chondrogenic differentiation of menstrual blood-derived stem cells on a nanofibrous scaffold. Int. J. Artif. Organs 35, 55-66.
18. Musina RA, Belyavski AV, Tarusova OV, Solovyova EV, Sukhikh GT (2008) Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull. Exp. Biol. Med. 145, 539-543.
19. Dimitrov R, Timeva T, Kyurkchiev D, Stamenova M, Shterev A, Kostova P et al. (2008) Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction 135, 551-558.
20. Ninomiya Y, Sugahara-Yamashita Y, Nakachi Y, Tokuzawa Y, Okazaki Y, Nishiyama M (2010) Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 394, 303-308.
21. Gregoire FM, Smas CM, Sul HS (1998) Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809.
22. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D (2009) Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol. Reprod. 80, 1136-1145.
23. Allickson JG, Sanchez A, Yefimenko N, Borlongan CV, Sanberg PR (2011) Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J. 3, 4-10.
24. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57.
25. Dani C, Smith AG, Dessolin S, Leroy P, Staccini L, Villageois P et al. (1997) Differentiation of embryonic stem cells into adipocytes in vitro. J. Cell Sci. 110, 1279-1285.
26. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ et al. (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37, e45.
27. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
28. Zemel'ko VI, Grinchuk TM, Domnina AP, Artsybasheva IV, Zenin VV, Kirsanov AA et al. (2011) Multipotent mesenchymal stem cells of desquamated endometrium: isolation, characterization and use as feeder layer for maintenance of human embryonic stem cell lines. Tsitologiia 53, 919-929.
29. Benvenuti S, Cellai I, Luciani P, Deledda C, Baglioni S, Giuliani C et al. (2007) Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J. Endocrinol. Invest. 30, RC26-RC30.
30. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS (2002) Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J. Clin. Endocrinol. Metab. 87, 2352-2358.
31. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B (2004) Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145, 401-406.
32. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL (2005) Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146, 1226-1235.
33. Bruedigam C, Eijken M, Koedam M, van de Peppel J, Drabek K, Chiba H et al. (2010) A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 28, 916-927.